ProfileGDS5678 / 1429218_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 4% 4% 4% 5% 5% 4% 4% 4% 4% 5% 4% 5% 5% 4% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.056554
GSM967853U87-EV human glioblastoma xenograft - Control 22.045514
GSM967854U87-EV human glioblastoma xenograft - Control 32.040164
GSM967855U87-EV human glioblastoma xenograft - Control 42.021665
GSM967856U87-EV human glioblastoma xenograft - Control 52.027865
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.066544
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.042154
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.024334
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.020224
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.041325
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.029344
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.027465
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.043865
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.036124